Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XLRN
DateTimeSourceHeadlineSymbolCompany
02/12/202114:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:XLRNAcceleron Pharma Inc
24/11/202120:48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
23/11/202110:21TipRanksMerck Completes Acquisition of Acceleron PharmaNASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202114:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202113:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
22/11/202112:02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
17/11/202119:26Business WireAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
17/11/202112:26Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
17/11/202112:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
12/11/202121:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
12/11/202112:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
10/11/202116:37Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
09/11/202122:31Business WireAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
08/11/202122:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
08/11/202122:15Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
04/11/202120:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
04/11/202120:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
04/11/202120:01Business WireAcceleron Reports Third Quarter 2021 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
28/10/202113:00Business WireAvoro Capital Issues Open Letter to Fellow Acceleron Pharma ShareholdersNASDAQ:XLRNAcceleron Pharma Inc
27/10/202112:10Business WireAcceleron Announces Third Quarter 2021 REBLOZYL® Net SalesNASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN